HomeRamiprilRamipril + Telmisartan And Hydrochlorothiazide

Does Ramipril Interact with Telmisartan And Hydrochlorothiazide?

Ramipril and Telmisartan And Hydrochlorothiazide have a major drug interaction according to U.S. FDA drug labeling data. Co-administration increases ramipril and ramiprilat exposure (2.3-2.4 fold Cmax, 1.5-2.1 fold AUC) while decreasing telmisartan levels. Additive pharmacodynamic effects may occur. The mechanism involves additive pharmacodynamic effects and increased ramipril/ramiprilat exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Ramipril Class
Angiotensin Converting Enzyme Inhibitor
Telmisartan And Hydrochlorothiazide Class
Angiotensin 2 Receptor Blocker
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Ramipril and Telmisartan And Hydrochlorothiazide occurs because additive pharmacodynamic effects and increased ramipril/ramiprilat exposure. Clinically, this means co-administration increases ramipril and ramiprilat exposure (2.3-2.4 fold cmax, 1.5-2.1 fold auc) while decreasing telmisartan levels. additive pharmacodynamic effects may occur. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Ramipril and your doctor is considering prescribing Telmisartan And Hydrochlorothiazide (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Ramipril(Altace)+💊 Telmisartan And Hydrochlorothiazide(Micardis-HCT)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Angiotensin Converting Enzyme Inhibitor
Drug B class
Angiotensin 2 Receptor Blocker
Source
NLP:telmisartan and hydrochlorothiazide

What this means in plain English

Co-administration increases ramipril and ramiprilat exposure (2.3-2.4 fold Cmax, 1.5-2.1 fold AUC) while decreasing telmisartan levels. Additive pharmacodynamic effects may occur.

About Ramipril and Telmisartan And Hydrochlorothiazide

Ramipril is an Angiotensin Converting Enzyme Inhibitor, while Telmisartan And Hydrochlorothiazide is an Angiotensin 2 Receptor Blocker. You may recognize them by the brand names Altace and Micardis-HCT. Both medications are taken by mouth. Both Ramipril and Telmisartan And Hydrochlorothiazide carry an FDA boxed warning — the agency's most serious safety designation.

What the FDA label says

"Additive pharmacodynamic effects and increased ramipril/ramiprilat exposure"

📖 Source: NLP:telmisartan and hydrochlorothiazide

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Ramipril and Telmisartan And Hydrochlorothiazide against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.